As expectations for refractive cataract surgery continue to rise, preoperative ocular surface optimization remains essential ...

Neuropathic pain develops when nerve damage causes the pain-sensing pathways in the nervous system to become hypersensitive. It can persist for months or years, and symptoms include extreme ...

The molecular signature of key sensory neurons that signal neuropathic pain has been uncovered, revealing a potential pathway for relieving chronic pain. “We know from direct human physiological ...

Researchers from The University of Texas at Dallas and their international colleagues have determined the molecular signature of human sleeping -­ or silent -­ nociceptors: sensory neurons that are ...

A systematic review of 21 studies found no strong evidence for cannabis being able to soothe neuropathic pain. The corresponding study was published in the Cochrane Database of Systematic Reviews.

Urcosimod targets immune-mediated inflammation and dysfunctional nerve signaling, showing potential in treating neuropathic corneal pain. Phase 2 trials demonstrated urcosimod's efficacy in reducing ...

A newly updated review suggests that there is limited evidence to support the use of cannabis-based medications for chronic neuropathic pain. Investigators analyzed 21 clinical trials involving more ...

Cannabis-based medicines have been widely promoted as a potential answer for people living with chronic nerve pain—but a major new review finds the evidence just isn’t there yet. After analyzing more ...

In 1994, the Task Force on Taxonomy of the International Association for the Study of Pain (IASP) introduced the concept of “neuropathic pain”, defined as “pain initiated or caused by a primary lesion ...

- The overall study dropout rate of ~4.4% is far below rates typically observed with other FDA approved chronic pain medicines - Based on the current Phase 2b trial enrollment pace and the interim ...

Survey data were collected from adults receiving care at a pain clinic. Participants completed demographic questions and standardized self-report measures (PROMIS Pain Intensity/Interference and the ...